Skip to main content
SpringerLink
Log in

T cell-mediated antigen presentation

A potential mechanism of infectious tolerance

  • Published:
Immunologic Research Aims and scope Submit manuscript

Abstract

Differentiation of the T cell repertoire and the physiology of T cell-mediated antigen presentation are reviewed in relation to mechanisms of self-tolerance. Recent research has indicated that T cell development is a continual process that optimizes partial recognition of self as a homeostatic set-point. Specific T cell antigen recognition of partial agonists is intrinsically linked to expression of class II MHC glycoproteins on T cells. Even ligands that act as TCR antagonists in IL-2 production assays have sufficient agonistic strength to induce expression of class II MHC glycoproteins on T cells. Thus, the intrinsic self-reactivity of the T cell repertoire may promote T-APC activity in vivo and may explain why thymic and peripheral T cells express low but significant levels of class II MHC glycoproteins. T-APC activity induces extensive apoptosis among responder T cells, causes desensitization among surviving responders, and has been implicated in the adoptive transfer of tolerance in the Lewis rat model of experimental autoimmune encephalomyelitis. Overall, these findings support a relationship between the partial recognition of self MHC ligands, expression of class II MHC glycoproteins on mature peripheral T cells, tolerogenic T cell-mediated antigen presentation, and desensitization of pathogenic self-reactive T cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sakaguchi, S, Sakaguchi, N: Thymus and autoimmunity: capacity of the normal thymus to produce pathogenic self-reactive T cells and conditions required for their induction of autoimmune disease. J Exp Med 1990;172:537–545.

    Article  PubMed  CAS  Google Scholar 

  2. Itoh, M, Takahashi, T, Sakaguchi, N, Kuniyasu, Y, Shimizu, J, Otsuka, F, Sakaguchi, S: Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol 1999;162:5317–5326.

    PubMed  CAS  Google Scholar 

  3. Suri-Payer, E, Amar, AZ, Thomton, AM, Shevach, EM: CD4+ CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol 1998;160:1212–1218.

    PubMed  CAS  Google Scholar 

  4. Modigliani, Y, Coutinho, A, Pereira, P, Le Douarin, N, Thomas-Vaslin, V, Burlen-Defranoux, O, Salaun, J, Bandeira, A: Establishment of tissue-specific tolerance is driven by regulatory T cells selected by thymicepithelium. Eur J Immunol 1996;26:1807–1815.

    Article  PubMed  CAS  Google Scholar 

  5. Le Douarin, N, Corbel, C, Bandeira, A, Thomas-Vaslin, V, Modigliani, Y, Coutinho, A, Salaun, J: Evidence for a thymus-dependent form of tolerance that is not based on elimination or anergy of reactive T cells. Immunol Rev 1996; 149:35–53.

    Article  PubMed  Google Scholar 

  6. Wilson, DB, Wilson, DH, Schroder, K: Acquired thymic tolerance and experimental allergic encephalomyelitis in the rat. I. Parameters and analysis of possible mechanisms. Eur J Immunol 1998;28:2770–2779.

    Article  PubMed  CAS  Google Scholar 

  7. Khoury, SJ, Sayegh, MH, Hancock, WW, Gallon, L, Carpenter, CB, Weiner, HL: Acquired tolerance to experimental autoimmune encephalomyelitis by intrathymic injection of myelin basic protein or its major encephalitogenic peptide. J Exp Med 1993;178:559–566.

    Article  PubMed  CAS  Google Scholar 

  8. Onodera, K, Volk, HD, Ritter, T, Kupiec-Weglinski, JW: Thymus requirement and antigen dependency in the “infectious” tolerance pathway in transplant recipients. J Immunol 1998;160:5765–5772.

    PubMed  CAS  Google Scholar 

  9. Stephenson, RP: A modification of receptor theory. Brit J Pharmacol 1956;11:379.

    PubMed  CAS  Google Scholar 

  10. Madrenas, J, Germain, RN: Variant TCR ligands: new insights into the molecular basis of antigen-dependent signal transduction and T-cell activation. Sem Immunol 1996;8:83–101.

    Article  CAS  Google Scholar 

  11. Kersh, GJ, Kersh, EN, Fremont, DH, Allen, PM: High- and low-potency ligands with similar affinities for the TCR: the importance of kinetics in TCR signaling. Immunity 1998;9:817–826.

    Article  PubMed  CAS  Google Scholar 

  12. Lanzavecchia, A, Lezzi, G, Viola, A: From TCR engagement to T cell activation: a kinetic view of T cell behavior. Cell 1999;96:1–4.

    Article  PubMed  CAS  Google Scholar 

  13. Janeway, CA, Jr., Dianzani, U, Portoles, P, Rath, S, Reich, EP, Rojo, J, Yagi, J, Murphy, DB: Cross-linking and conformational change in T-cell receptors: role in activation and in repertoire selection. Cold Spring Harb Symp Quant Biol 1989;54:657–666.

    PubMed  CAS  Google Scholar 

  14. Janeway, CA, Jr., Bottomly, K: Responses of T cells to ligands for the T-cell receptor. Semin Immunol 1996;8:108–115.

    Article  PubMed  Google Scholar 

  15. Alam, SM, Davies, GM, Lin, CM, Zal, T, Nasholds, W, Jameson, SC, Hogquist, KA, Gascoigne, NR, Travers, PJ: Qualitative and quantitative differences in T cell receptor binding of agonist and antagonist ligands. Immunity 1999;10:227–237.

    Article  PubMed  CAS  Google Scholar 

  16. Ott, S, Costa, T: Guanine nucleotide-mediated inhibition of opioid agonist binding. Modulatory effects of ions and of receptor occupancy. Biochem Pharmacol 1989;38:1931–1939.

    Article  PubMed  CAS  Google Scholar 

  17. Sibley, DR, Mahan, LC, Creese, I: Dopamine receptor binding on intact cells. Absence of a highaffinity agonist-receptor binding state. Mol Pharmacol 1983;23:295–302.

    PubMed  CAS  Google Scholar 

  18. Hogquist, KA, Jameson, SC, Heath, WR, Howard, JL, Bevan, MJ, Carbone, FR: T cell receptor antagonist peptides induce positive selection. Cell 1994;76:17–27.

    Article  PubMed  CAS  Google Scholar 

  19. Saito, T, Watanabe, N: Positive and negative thymocyte selection. Crit Rev Immunol 1998;18:359–370.

    PubMed  CAS  Google Scholar 

  20. Teh, HS, Motyka, B, Teh, SJ: Influence of the affinity of selecting ligands on T cell positive and negative selection and the functional maturity of the positively selected T cells. Crit Rev Immunol 1997;17:399–410.

    PubMed  CAS  Google Scholar 

  21. Williams, O, Tanaka, Y, Tarazona, R, Kioussis, D: The agonist-antagonist balance in positive selection. Immunol Today 1997;18:121–126.

    Article  PubMed  CAS  Google Scholar 

  22. Hogquist, KA, Bevan, MJ: The nature of the peptide/MHC ligand involved in positive selection. Semin Immunol 1996;8:63–68.

    Article  PubMed  CAS  Google Scholar 

  23. Goldrath, AW, Bevan, MJ: Selecting and maintaining a diverse T-cell repertoire. Nature 1999;402:255–262.

    Article  PubMed  CAS  Google Scholar 

  24. Kisielow, P, Hluthmann, H, Staerz, UD, Steimmetz, M, von Boehmer, H: Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature 1988;333:742–746.

    Article  PubMed  CAS  Google Scholar 

  25. Jameson, SC, Hogquist, KA, Bevan, MJ: Specificity and flexibility in thymic selection. Nature 1994;369:750–752.

    Article  PubMed  CAS  Google Scholar 

  26. Auphan, N, Jezo-Bremond, A, Schonrich, G, Hammerling, G, Amold, B, Malissen, B, Schmitt-Verhulst, AM: Threshold to lerance in H-2Kb-spec ific TCR transgenic mice expressing mutant H-2Kb: conversion of helper-indenpendent to helper-dependent CTL. Int Immunol 1992;4:1419–1428.

    Article  PubMed  CAS  Google Scholar 

  27. Husbands, SD, Schonrich, G, Arnold, B, Chandler, PR, Simpson, E, Philpott, KL, Tomlinson, P, O'Reilly, L, Cooke, A, Mellor, AL: Expression of major histocompatibility complex class I antigens at low levels in the thymus induces T cell tolerance via a nondeletional mechanism. Eur J Immunol 1992;22:2655–2661.

    Article  PubMed  CAS  Google Scholar 

  28. Auphan, N, Schonrich, G, Malissen, M, Barad, M, Hammerling, G, Arnold, B, Malissen, B, Schmitt-Verhulst, AM: Influence of antigen density on degree of cloral deletion in T cell receptor transgenic mice. Int Immunol 1992;4:541–547.

    Article  PubMed  CAS  Google Scholar 

  29. Schorich, G, Kalinke, U, Momburg, F, Malissen, M, Schmitt-Verhulst, AM, Malissen, B, Hammerling, GJ, Arnold, B: Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic to lerance induction. Cell 1991;65:293–304.

    Article  Google Scholar 

  30. Teh, HS, Kishi, H, Scott, B, Von Boehmer, H: Deletion of autospecific T cells in T cell receptor (TCR) transgenic mice spares cells with normal TCR levels and low levels of CD8 molecules. J Exp Med 1989;169:795–806.

    Article  PubMed  CAS  Google Scholar 

  31. Budd, RC, Mixter, PF: The origin of CD4-CD8-TCRαβ+ thymocytes: a model based on T-cell receptor avidity. Immunol Today 1995;16:428–431.

    Article  PubMed  CAS  Google Scholar 

  32. Mannie, MD, Rosser, JM, White, GA: Autologous rat myelin basic protein is a partial agonist that is converted into a full antagonist upon blockade of CD4. Evidence for the integration of efficacious and nonefficacious signals during T cell antigen recognition. J Immunol 1995;154:2642–2654.

    PubMed  CAS  Google Scholar 

  33. Renard, V, Delon, J, Luescher, IF, Malissen, B, Vivier, E, Trautmann, A: The CD8 beta polypeptide is required for the recognition of analtered peptide ligandasanagonist. Eur J Immunol 1996;26:2999–3007.

    Article  PubMed  CAS  Google Scholar 

  34. Kersh, GJ, Hedrick, SM: Role of TCR specificity in CD4 versus CD8 lineage commitment. J Immunol 1995;154:1057–1068.

    PubMed  CAS  Google Scholar 

  35. Strasser, A, Harris, AW, von Boehmer, H, Cory, S: Positive and negative selection of T cells in T-cell receptor transgenic mice expressinga bcl-2 transgene. Proc Natl Acad Sci USA 1994;91:1376–1380.

    Article  PubMed  CAS  Google Scholar 

  36. Goldrath, AW, Bevan, MJ: Lowaffinity ligands for the TCR drive proliferation of mature CD 8+ T cells in lymphopenichosts. Immunity 1999;11:183–190.

    Article  PubMed  CAS  Google Scholar 

  37. Ernst, B, Lee, DS, Chang, JM, Sprent, J, Surh, CD: The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity 1999;11:173–181.

    Article  PubMed  CAS  Google Scholar 

  38. Freitas, AA, Rocha, B: Peripheral T cell survival. Curr Opin Immunol 1999;11:152–156.

    Article  PubMed  CAS  Google Scholar 

  39. Janeway, CA, Jr.: T-cell development: a role for self-peptides in positive selection. Curr Biol 1999; 9:R342-R345.

    Article  PubMed  CAS  Google Scholar 

  40. McGargill, MA, Hogquist, KA: Antigen-induced correcptor downregulation on thymocytes is not a result of apoptosis. J Immunol 1999;162:1237–1245.

    PubMed  CAS  Google Scholar 

  41. Sprent, J, Schaefer, M, Hurd, M, Surh, CD, Ron, Y: Mature murine B and T cells transferred to SCID mice can survive indefinitely and many maintaina virginphenotype. J Exp Med 1991;174:717–728.

    Article  PubMed  CAS  Google Scholar 

  42. Takeda, S, Rodewald, HR, Arakawa, H, Bluethmann, H, Shimizu, T: MHC class II molecules are not required for survival of newly generated CD4+T cells, butaffect their long-term life span. Immunity 1996;5:217–228.

    Article  PubMed  CAS  Google Scholar 

  43. Brocker, T: Survival of mature CD4 T lymphocytes is dependent on major histocompatibility complex class II-expressing dendritic cells. J Exp Med 1997;186:1223–1232.

    Article  PubMed  CAS  Google Scholar 

  44. Rooke, R, Waltzinger, C, Benoist, C, Mathis, D: Targeted complementation of MHC class II deficiency by intrathymic delivery of recombimantade noviruses. Immunity 1997;7:123–134.

    Article  PubMed  CAS  Google Scholar 

  45. Yamada, H, Ninomiya, T, Hashimoto, A, Tamada, K, Takimoto, H, Nomoto, K: Positive selection of extrathymically developed T cells by self-antigens. J Exp Med 1998; 188:779–784.

    Article  PubMed  CAS  Google Scholar 

  46. Tanchot, C, Lemonnier, FA, Perarnau, B, Freitas, AA, Rocha, B: Differential requirements for survival and proliferation of CD8 naive or memory T cells. Science 1997;276:2057–2062.

    Article  PubMed  CAS  Google Scholar 

  47. Viret, C, Wong, FS, Janeway, CA, Jr.: Designing and maintaining the mature TCR repertoire: the continuum of self-peptide: self-MHC complex recognition. Immunity 1990;10:559–568.

    Article  Google Scholar 

  48. Kinberg, J, Berns, A, von Boehmer, H: Peripheral T cell survival requires continual ligation of the T cell receptor to major histocompatibility complex-encoded molecules. J Exp Med 1997;186:1269–1275.

    Article  Google Scholar 

  49. Goodnow, CC: Balaracing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc Natl Acad Sci USA 1996;93:2264–2271.

    Article  PubMed  CAS  Google Scholar 

  50. Rocha, B, von Boehmer, H: Peripheral selection of the T cell repertoire. Science 1991;251:1225–1228.

    Article  PubMed  CAS  Google Scholar 

  51. Ferber, I, Schonrich, G, Schenkel, J, Mellor, AL, Hammerling, GJ, Arnold, B: Levels of peripheral T cell to lerance induced by different doses of tolerogen. Science 1994; 263:674–676.

    Article  PubMed  CAS  Google Scholar 

  52. Schonrich, G, Momburg, F, Malissen, M, Schmitt-Verhulst, A-M, Malissen, B, Hammerling, GJ, Arnold, B: Distinct mechansms of extrathymic T cell tolerance due to differential expression of selfantigen. Int Immunol 1992;4:581–590.

    Article  PubMed  CAS  Google Scholar 

  53. Blish, CA, Dillon, SR, Farr, AG, Fink, PJ: Anergic CD8+T cells can persist and function in vivo. J Immunol 1999;163:155–164.

    PubMed  CAS  Google Scholar 

  54. Dillon, SR, MacKay, VL, Fink, PJ: A functionally compromised intermediate in extrathymic CD8+ T cell deletion. Immunity 1995;3:321–333.

    Article  PubMed  CAS  Google Scholar 

  55. Lenardo, MJ: Fas and the art of lymphocyte maintenance. J Exp Med 1996;183:721–724.

    Article  PubMed  CAS  Google Scholar 

  56. Landolfi, MM, Van Houten, N, Russell, JQ, Scollay, R, Parnes, JR, Budd, RC: CD2−CD4−CD8− lymph node T lymphocytes in MRL ipr/ipr mice are derived from a CD2+CD4+CD8+ thymic precursor. J Immunol 1993;151:1086–1096.

    PubMed  CAS  Google Scholar 

  57. Reap, EA, Felix, NJ, Wolthusen, PA, Kotzin, BL, Cohen, PL, Eisenberg, RA: bcl-2 transgenic L pr mice show profound enhancement of lymphadenopathy. J Immunol 1995;155:5455–5462.

    PubMed  CAS  Google Scholar 

  58. von Boehmer, H, Kirberg, J, Rocha, B: An unusual lineage of alpha/beta T cells that contains autoreactive cells. J Exp Med 1991; 174:1001–1008.

    Article  Google Scholar 

  59. Mehal, WZ, Crispe, IN: TCR ligation on CD8+ T cells creates double-negative cells in vivo. J Immunol 1998;161:1686–1693.

    PubMed  CAS  Google Scholar 

  60. Evavold, BD, Allen, PM: Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science 1991;252:1308–1310.

    Article  PubMed  CAS  Google Scholar 

  61. Evavold, BD, Sloan-Lancaster, J, Hsu, BL, Allen, PM: Separation of Thelper 1 clone cytolysis from proliferation and lymphokine production using analog peptides. J Immunol 1993;150:3131–3140.

    PubMed  CAS  Google Scholar 

  62. Racioppi, L, Ronchese, F, Matis, LA, Germain, RN: Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling. J Exp Med 1993;177:1047–1060.

    Article  PubMed  CAS  Google Scholar 

  63. Bachmann, MF, Speiser, DE, Zakarian, A, Ohashi, PS: Inhibition of TCR triggering by a spectrum of altered peptide ligands suggests the mechanism for TCR antagonism. Eur J Immunol 1998;28:3110–3119.

    Article  PubMed  CAS  Google Scholar 

  64. Sloan-Lancaster, J, Evavold, BD, Allen, PM: Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature 1993;363:156–159.

    Article  PubMed  CAS  Google Scholar 

  65. Sloan-Lancaster, J, Evavold, BD, Allen, PM: Th2 cell clonal anergy as a consequence of partial activation. J Exp Med 1994;180:1195–1205.

    Article  PubMed  CAS  Google Scholar 

  66. Ruiz, PJ, Garren, H, Hirschberg, DL, Langer-Gould, AM, Levite, M, Karpuj, MV, Southwood, S, Sette, A, Conlon, P, Steinman, L: Microbial epitopesact as altered peptide ligands to prevent experimental autoimmune encephalomyelitis. J Exp Med 1999;189:1275–1284.

    Article  PubMed  CAS  Google Scholar 

  67. Nicholson, LB, Murtaza, A, Hafler, BP, Sette, A, Kuchroo, VK: A T cell receptor antagonist peptide induces T cells that mediate by stander suppression and prevent autoimmune encephalomy elitis induced with multiple myelin antigens. Proc Natl Acad Sci USA 1997;94:9279–9284.

    Article  PubMed  CAS  Google Scholar 

  68. Brocke, S, Gijbels, K, Allegretta, M, Ferber, I, Piercy, C, Blankenstein, T, Martin, R, Utz, U, Karin, N, Mitchell, D: Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature 1996;379:343–346.

    Article  PubMed  CAS  Google Scholar 

  69. Basu, D, Williams, CB, Allen, PM: In vivo antagonism of a T cell response by an endogenously expressed ligand. Proc. Natl Acad Sci USA 1998;95:14,332–14,336

    Article  CAS  Google Scholar 

  70. Jordan, MS, Riley, MP, von Boehmer, H, Caton, AJ: Anergy and suppression regulate CD4(+) T cell responses to a self peptide. Eur J Immunol 2000;30:136–144.

    Article  PubMed  CAS  Google Scholar 

  71. Araneo, BA, Yowell, RL: MHC-linked immune response suppression mediated by T cells bearing 1-A-encoded determinants. J Immunol 1985;135:73–79.

    PubMed  CAS  Google Scholar 

  72. Ben-Nun, A, Strauss, W, Leeman, SA, Cohn, LE, Murre, C, Duby, A, Seidman, JG, Glimcher, LH: An la-positive mouse T-cell clone is functional in presenting antigen to other T cells. Immunogenetics 1985;22:123–130

    Article  PubMed  CAS  Google Scholar 

  73. Graf, L, Koch, N, Schirrmacher, V: Expression of Ia antigens in a murine T-lymphoma variant. Mol Immunol 1985;22:1371–1377.

    Article  PubMed  CAS  Google Scholar 

  74. Heuer, J, Kolsch, E: Functional studies on the role of I-A molecules expressed by the antigen-specific T suppressor cell clone HF1. J Immunol 1985;134:4031–4034.

    PubMed  CAS  Google Scholar 

  75. Krammer, PH, Hudson, L, Sprent, J: Fe-receptors, Ia-antigens, and immunoglobulin on normal and activated mouse T lymphocytes. J Exp Med 1975;142:1403–1415.

    Article  PubMed  CAS  Google Scholar 

  76. Lorber, MI, Loken, MR, Stall, AM, Fitch, FW, I-A antigens on cloned alloreactive murine T lymphocytes are acquired passively. J Immunol 1982;128:2798–2803.

    PubMed  CAS  Google Scholar 

  77. Michaelides, M, McKenzie, IF: Detection of Ia alloantigens on phytobemagglutinin-stimulated T blast cells. Transplantation 1981;31:330–333.

    Article  PubMed  CAS  Google Scholar 

  78. Osbome, BA, Rudikoff, S: Murine thymocyte and splenocyte la antigens are indistinguishable by two-dimensional gel electrophoresis. J Immunol 1983;131:1386–1390.

    Google Scholar 

  79. Reske-Kunz, AB, Reske, K, Rude, E: Cloned murine Ia+ BK-BI-2.6.C6 T cells function as accessory cells presenting protein antigens to long-term-cultured antigen-specific T cell lines. J Immunol 1986;136:2033–2040.

    PubMed  CAS  Google Scholar 

  80. Sharrow, SO, Mathieson, BJ, Singer, A: Cell surface appearance of unexpected host MHC determinants on thymocytes from radiation bone marrow chimeras. J Immunol 1981;126:1327–1335.

    PubMed  CAS  Google Scholar 

  81. Vadas, MA, Miller, JF, McKenzie, IF, Chism, SE, Shen, FW, Boyse, EA, Gamble, JR, Whitelaw, AM: Ly and Ia antigen phenotypes of T cells involved in delayed-type hypersensitivity and in suppression. J Exp Med 1976;144:10–19.

    Article  PubMed  CAS  Google Scholar 

  82. Bevan, DJ, Chisholm, PM: Coexpression of CD4 and CD8 molecules and de novo expression of MHC class II antigenson activated rat T cells. Immunol 1986;59:621–625

    CAS  Google Scholar 

  83. Kira, J, Itoyama, Y, Goto, I: Generation of CD4+ blastoid T cells showing marked upregulation of CD4, class I and II MHC, and IL2 receptor mole cules is required for the expression of potent encephalito genicity. Cell Immunol 1989;123:264–275.

    Article  PubMed  CAS  Google Scholar 

  84. Reske, K, Mohle, U, Sun, D, Wekerle, H: Synthesis and cell surface display of class II determinants by long-term propagated rat T line cells. Eur J Immunol 1987;17:909–914.

    Article  PubMed  CAS  Google Scholar 

  85. Sopori, ML, Cohen, DA, Cherian, S, Kaplan, AM: Antigen presentation in the rat: role of a nonadherent, nonphagocytic, W3/13, OX-6 positive T cell in the presentation of antigen to primed T lymphocytes. Cell Immunol 1984;87:177–191.

    Article  PubMed  CAS  Google Scholar 

  86. Sopori, ML, Cohen, DA, Cherian, S, Perrone, RS, Kaplan, AM: Antigen presentation in the rat. II. An Ia+ radiosensitive T cell can present antigen to primed Ia-T cells. J Immunol 1985;134:1369–1373.

    PubMed  CAS  Google Scholar 

  87. Sun, D, Woodland, DL, Coleclough, C, Wendling, U, Reske, K: An MHC class II-expressing T cell clone presenting conventional antigen lacks the ability to present bacterial superantigen. Intern Immunol 1995;7:1079–1085.

    Article  CAS  Google Scholar 

  88. Reizis, B, Schramm, C, Cohen, IR, Mor, F: Expression of major histocompatibility complex class II molecules in rat T cells. Eur J Immunol 1994;24:2796–2802.

    Article  PubMed  CAS  Google Scholar 

  89. Cells, E, Saibara, T: Binding of T cell receptor to major histocompatibility complex class II-peptide complexes at the single-cell level results in the induction of antigen unresponsiveness (anergy). Eur. J Immunol 1992;22:3127–3134.

    Article  Google Scholar 

  90. Celis, E, Goodwin, JJ, Saibara, T: Peptide-induced proliferation and lymphokine production in human T cells in the absence of antigen-presenting cells: role of T-cell activation state and costimulatory signals. Hum Immunol 1992;34:173–180.

    Article  PubMed  CAS  Google Scholar 

  91. Evans, RL, Faldetta, TJ, Humphreys, RE, Pratt, DM, Yunis, EJ, Schlossman, SF: Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express Ia-like antigens. J Exp Med 1978;148:1440–1445.

    Article  PubMed  CAS  Google Scholar 

  92. Grunow, R, Frutig, K, Pichler, WJ: Anergy induction in human CD4+ T-cell clones by stimulation with soluble peptides does not require cell proliferation and is accompanied by elevated IL4 production. Cell Immunol 1996;173:79–86.

    Article  PubMed  CAS  Google Scholar 

  93. Ko, HS, Fu, SM, Winchester, RJ, Yu, DT, Kunkel, HG: Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen-and antigen-activated T cells. J Exp Med 1979;150:246–255.

    Article  PubMed  CAS  Google Scholar 

  94. Lamb, JR, Feldmann, M: Essential requirement for major histocompatibility complex recognition in T-cell tolerance induction. Nature 1984;308:72–74.

    Article  PubMed  CAS  Google Scholar 

  95. LaSalle, JM, Ota, K, Hafler, DA: Presentation of autoantigen by human T cells. J Immunol 1991; 147:774–780.

    PubMed  CAS  Google Scholar 

  96. La Salle, JM, Toneguzzo, F, Saadeh, M, Golan, DE, Taber, R, Hafler, DA: T-cell presentation of antigen requires cell-to-cell contact for proliferation and anergy induction. Differential MHC requirements for superantigen and autoantigen. J Immunol 1993;151:649–657.

    Google Scholar 

  97. Mauri, D, Wyss-Coray, T, Gallati, H, Pichler, WJ: Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells: I. Involvement of the CD80-CD28 adhesion molecules. J Immunol 1995;155:118–127.

    PubMed  CAS  Google Scholar 

  98. Reinherz, EL, Kung, PC, Pesando, JM, Ritz, J, Goldstein, G, Schlossman, SF: Ia determinants on human T-cell subsets defined by monoclonal antibody. Activation stimuli required for expression. J Exp Med 1979;150:1472–1482.

    Article  PubMed  CAS  Google Scholar 

  99. Satyaraj, E, Rath, S, Bal, V: Induction of tolerance in freshly isolated alloreactive T cells by activated T cell stimulators is not due to the absence of CD28-B7 interaction. J Immunol 1995;155:4669–4675.

    PubMed  CAS  Google Scholar 

  100. Yu, DT, McCune, JM, Fu, SM, Winchester, RJ, Kunkel, HG: Two types of Ia-positive T cells. Synthesis and exchange of Iaantigens. J Exp Med 1980;152:89s-98s.

    PubMed  CAS  Google Scholar 

  101. La Salle, JM, Tolentino, PJ, Freeman, GJ, Nadler, LM, Hafler, DA: Early signaling defects in human T cells anergized by T cell presentation of autoantigen. J Exp Med 1992;176:177–186.

    Article  Google Scholar 

  102. Satyaraj, E, Rath, S, Bal, V: Induction of tolerance in freshly isolated alloreactive CD4+ T cells by activated T cell stimulators. Eur J Immunol 1994;24:2457–2461.

    Article  PubMed  CAS  Google Scholar 

  103. Bettens, F, Frei, E, Frutig, K, Mauri, D, Pichle, WJ, Wyss-Coray, T: Noncytotoxic human CD4+T-cell clones presenting and simultaneously responding to an antigen die of apoptosis. Cell Immunol 1995;161:72–78.

    Article  PubMed  CAS  Google Scholar 

  104. Pichler, WJ, Wyss-Coray, T: T cell as antigen-presenting cells. Immunol Today 1994;15:312–315.

    Article  PubMed  CAS  Google Scholar 

  105. La Salle, JM, Toneguzzo, F, Saadeh, M, Golan, DE, Tabe, R, Hafler, D: T cell presentation of antigen requires cell-to-cell contact for proliferation and anergy induction: differential MHC requirements for superantigen and autoantigen. J Immunol 1993;151:649–657.

    Google Scholar 

  106. La Salle, JM, Hafler, DA: T cell anergy. FASEB J 1994;8:601–608.

    Google Scholar 

  107. Celis, E, Saibara, T: Binding of T cells receptor to major histocompatibility complex class II peptide complexes at the single-cell level results in the induction of antigen unresponsiveness (anergy). Eur J Immunol 1992;22:3127–3134.

    Article  PubMed  CAS  Google Scholar 

  108. Mauri, D, Wyss-Coray, T, Gallati, H, Pichler, WJ: Antigen-presenting T cells induce the development of cytotoxic CD4+T cells. 1. involvement of the CD80-CD28 adhesion molecules. J Immunol 1995;155:118–127.

    PubMed  CAS  Google Scholar 

  109. Lamb, JR, Skidmore, BJ, Green, N, Chiller, JM, Feldman, M: Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin. J Exp Med 1983; 157:1434.

    Article  PubMed  CAS  Google Scholar 

  110. Mamie, MD, White, GA, Lake, KR, Nardella, JP, Marinakis, CA, McConnell, TJ: T-helper lymphocytes specific for myelin basic protein: low-density activation prolongs a postactivation refractory phase marked by decreased pathogenicity and enhanced sensitivity to anergy. Cell Immunol 1996;172:108–117.

    Article  Google Scholar 

  111. Mannie, MD, Rendall, SK, Arnold, PY, Nardella, JP, White, GA: Anergy-associated T cell antigen presentation. A mechanism of infectious tolerance in experimental autoimmune encephalomyelitis. J Immunol 1996;157:1062–1070.

    PubMed  CAS  Google Scholar 

  112. Mannie, MD, White, GA, Nardella, JP, Davidian, DK, Arnold, PY: Partial agonism elicits an enduring phase of T-cell-mediacated antigen presentation. Cell Immunol 1998;186:83–93.

    Article  PubMed  CAS  Google Scholar 

  113. Mannie, MD, Nardella, JP, White, GA, Arnold, PY, Davidian, DK: Class II MHC/peptide complexes on T cell antigen-presenting cells: agonistic antigen recognition inhibits subsequent antigen presentation. Cell Immunol 1998;186:111–120.

    Article  PubMed  CAS  Google Scholar 

  114. Arnold, PY, Davidian, DK, Mannie, MD: Antigen presentation by T cells: T cell receptor ligation promotes antigen acquisition from professional antigen-presenting cells. Eur J Immunol 1997;27:3198–3205.

    Article  PubMed  CAS  Google Scholar 

  115. Walker, MR, White, GA, Nardella, JP, Mannie, MD: An autologous self-antigen differentially regulates expression no fI-A glycoproteins and B7 costimulatory molecules on CD4−CD8−T helpercells. J Leukoc Biol 1999;66:120–126.

    PubMed  CAS  Google Scholar 

  116. Patel, DM, Arnold, PY, White, GA, Nardella, JP, Mannie, MD: Class 11 MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition. J Immunol 1999;163:5201–5210.

    PubMed  CAS  Google Scholar 

  117. Raposo, G, Nijman, HW, Stoorvogel, W, Liejendekker, R, Harding, CV, Melief, CJ, Geuze, HJ: B lymphocytes secrete antigen-presenting vesicles. J Exp Med 1996;183:1161–1172.

    Article  PubMed  CAS  Google Scholar 

  118. Arnold, PY, Mannie, MD: Vesicles bearing MHC class II molecules mediate transfer of antigen from antigen-presenting cells to CD4+ T cells. Eur J Immunol 1999;29:1363–1373.

    Article  PubMed  CAS  Google Scholar 

  119. Mannie, MD: A unified model for T cell antigen recognition and thymic selection of the T cell repertoire. J Theor Biol 1991;151:169–192.

    Article  PubMed  CAS  Google Scholar 

  120. Mannie, MD: Immunological self/nonself discrimination: intergration of self vs nonself during cognate T cell interactions with antigen-presenting cells. Immunol Res. 1999;19:65–87.

    PubMed  CAS  Google Scholar 

Download references

Author information

Author notes

  1. Mark D. Mannie

    Present address: Department of Microbiology and Immunology, East Carolina University School of Medicine, 27856-4354, Greenville, NC

Authors and Affiliations

    Authors
    1. Mark D. Mannie
      View author publications

      You can also search for this author in PubMed Google Scholar

    Rights and permissions

    Reprints and permissions

    About this article

    Cite this article

    Mannie, M.D. T cell-mediated antigen presentation. Immunol Res 23, 1–21 (2001). https://doi.org/10.1385/IR:23:1:01

    Download citation

    • Issue Date:

    • DOI: https://doi.org/10.1385/IR:23:1:01

    Key Words

    Search

    Navigation